Investors
Investor Relations
Find information about Lundbeck’s financial health, read our annual report and other investor presentations, and look up key facts, figures, and details of our share.
LATEST NEWS
- Accelerated growth for strategic brands (+21% CER) drives revenue up 13% CER in the first nine months of 2024
- Lundbeck announces positive results from phase III pivotal trial (SUNRISE) of Vyepti® (eptinezumab) in migraine prevention
- Capital Markets Event 2024: Lundbeck to showcase progress on Focused Innovator Strategy driving sustainable long-term growth
Contact Investor Relations
Aktionærportal
Som aktionær kan du via portalen få adgang til en lang række aktionærinformationer - bl.a. kan du se din aktiebeholdning, vælge hvilken aktionærinformation du ønsker at modtage, tilmelde dig generalforsamlingen eller afgive fuldmagt.
Investor portal
As a shareholder you can access a wide range of investor information. Among other things, you can view your shareholding, choose which investor information you wish to receive, register for the AGM or appoint a proxy.